Droplet screening set to accelerate immunotherapies into the clinic
Single-cell technique eliminates inefficiencies when identifying immune cells active against specific cancers
A device that screens immune system cells in droplets can select and isolate those that can target specific tumours within days, shaving months off current methods for creating immunotherapies. The system could also be used to personalise cancer treatments.